Emerging Nicotine Alternatives: A New Challenge for FDA Regulation

The introduction of synthetic nicotine alternatives like 6-methyl nicotine in vapes is raising concerns due to their potential higher potency and addictive nature compared to traditional nicotine. The FDA and researchers are investigating these compounds, but current data is insufficient. Regulatory gaps allow these products to be marketed without FDA authorization, posing risks to consumers.

Related Keywords

Indonesia ,India ,Denver ,Colorado ,United States ,United Kingdom ,China ,Japan ,American ,Chinese ,Samuel Benaim ,Sven Jordt ,Imad Damaj ,Allison Boughner ,European Union Classification ,Reuters ,Department Of Pharmacology ,Virginia Commonwealth University ,Duke University ,Charlie Holdings ,Drug Administration ,Charlie Holdings Inc ,American Vapor Manufacturers Association ,British American Tobacco ,Altria Group ,Holdings Inc ,Ryan Stump ,Spree Bar ,Novel Compounds ,Novel Compound ,Aroma King ,European Union ,Zinwi Biotech ,